FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 347:1505-1511 November 7, 2002 Number 19 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF PDA Full Text Purchase this article Letters Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they exist. The article ends with the author's clinical recommendations.

A 66-year-old man without diabetes has worsening high blood pressure, to 160/100 mm Hg. He has a serum creatinine level of 1.8 mg per deciliter (159 µmol per liter), an estimated glomerular filtration rate of 40 ml per minute per 1.73 m² of body-surface area, proteinuria (2+), and a total protein level of 84 mg per deciliter and a creatinine level of . . . [Full Text of this Article]

The Clinical Problem

Strategies and Evidence

Proteinuria as a Marker of Kidney Damage

Glomerular Filtration Rate

The Clinical Plan of Action

Strict Blood-Pressure Control

Angiotensin-Converting–Enzyme Inhibitors

Areas of Uncertainty

Therapy with Antihypertensive Agents

Dietary Protein Restriction

Lipid-Lowering Agents

Cessation of Tobacco Use

Guidelines

Conclusions and Recommendations

Source Information

From the Division of Nephrology, Tufts–New England Medical Center, Boston.

Related Letters:

Nondiabetic Kidney Disease
Pitts D. B., Goto A., Levey A. S.
Extract | Full Text | PDF  
N Engl J Med 2003; 348:762-763, Feb 20, 2003. Correspondence

This article has been cited by other articles:

• Warnock, D. G., Daina, E., Remuzzi, G., West, M. (2010). Enzyme Replacement Therapy and Fabry Nephropathy. CJASN 5: 371-378 [Abstract] [Full Text]  
• Reichlin, T., Hochholzer, W., Stelzig, C., Laule, K., Freidank, H., Morgenthaler, N. G., Bergmann, A., Potocki, M., Noveanu, M., Breidthardt, T., Christ, A., Boldanova, T., Merki, R., Schaub, N., Bingisser, R., Christ, M., Mueller, C. (2009). Incremental value of copeptin for rapid rule out of acute myocardial infarction.. J Am Coll Cardiol 54: 60-68 [Abstract] [Full Text]  
• West, M., Nicholls, K., Mehta, A., Clarke, J. T.R., Steiner, R., Beck, M., Barshop, B. A., Rhead, W., Mensah, R., Ries, M., Schiffmann, R. (2009). Agalsidase Alfa and Kidney Dysfunction in Fabry Disease. J. Am. Soc. Nephrol. 20: 1132-1139 [Abstract] [Full Text]  
• Tongers, J., Losordo, D. W. (2007). Frontiers in Nephrology: The Evolving Therapeutic Applications of Endothelial Progenitor Cells. J. Am. Soc. Nephrol. 18: 2843-2852 [Abstract] [Full Text]  
• Breidthardt, T., Laule, K., Strohmeyer, A.-H., Schindler, C., Meier, S., Fischer, M., Scholer, A., Noveanu, M., Christ, M., Perruchoud, A. P., Mueller, C. (2007). Medical and Economic Long-term Effects of B-Type Natriuretic Peptide Testing in Patients with Acute Dyspnea. Clin. Chem. 53: 1415-1422 [Abstract] [Full Text]  
• Buettner, H. J., Mueller, C., Gick, M., Ferenc, M., Allgeier, J., Comberg, T., Werner, K. D., Schindler, C., Neumann, F.-J. (2007). The impact of obesity on mortality in UA/non-ST-segment elevation myocardial infarction. Eur Heart J 28: 1694-1701 [Abstract] [Full Text]  
• Schiffmann, R., Askari, H., Timmons, M., Robinson, C., Benko, W., Brady, R. O., Ries, M. (2007). Weekly Enzyme Replacement Therapy May Slow Decline of Renal Function in Patients with Fabry Disease Who Are on Long-Term Biweekly Dosing. J. Am. Soc. Nephrol. 18: 1576-1583 [Abstract] [Full Text]  
• Sprangers, B., Evenepoel, P., Vanrenterghem, Y. (2006). Late Referral of Patients With Chronic Kidney Disease: No Time to Waste. Mayo Clin Proc. 81: 1487-1494 [Abstract] [Full Text]  
• Jones, C., Roderick, P., Harris, S., Rogerson, M. (2006). Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease. Nephrol Dial Transplant 21: 2133-2143 [Abstract] [Full Text]  
• Schiffmann, R., Ries, M., Timmons, M., Flaherty, J. T., Brady, R. O. (2006). Long-term therapy with agalsidase alfa for Fabry disease: safety and effects on renal function in a home infusion setting. Nephrol Dial Transplant 21: 345-354 [Abstract] [Full Text]  
• Levey, A. S., Mulrow, C. D. (2005). An Editorial Update: What Level of Blood Pressure Control in Chronic Kidney Disease?. ANN INTERN MED 143: 79-81 [Full Text]  
• Jafar, T. H., Schmid, C. H., Levey, A. S. (2005). Serum Creatinine as Marker of Kidney Function in South Asians: A Study of Reduced GFR in Adults in Pakistan. J. Am. Soc. Nephrol. 16: 1413-1419 [Abstract] [Full Text]  
• Jadoul, M (2005). Optimal care of lupus nephritis patients. Lupus 14: 72-76 [Abstract]  
• Jones, R.C., Francis, G. S., Lauer, M. S. (2004). Predictors of mortality in patients with heart failure and preserved systolic function in the Digitalis Investigation Group trial. J Am Coll Cardiol 44: 1025-1029 [Abstract] [Full Text]  
• Mueller, C, Neumann, F-J, Perruchoud, A P, Buettner, H J (2004). Renal function and long term mortality after unstable angina/non-ST segment elevation myocardial infarction treated very early and predominantly with percutaneous coronary intervention. Heart 90: 902-907 [Abstract] [Full Text]  
• Rimon, E., Kagansky, N., Cojocaru, L., Gindin, J., Schattner, A., Levy, S. (2004). Can creatinine clearance be accurately predicted by formulae in octogenarian in-patients?. QJM 97: 281-287 [Abstract] [Full Text]  
• Sarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., Parfrey, P., Pfeffer, M., Raij, L., Spinosa, D. J., Wilson, P. W. (2003). Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Hypertension 42: 1050-1065 [Full Text]  
• Sarnak, M. J., Levey, A. S., Schoolwerth, A. C., Coresh, J., Culleton, B., Hamm, L. L., McCullough, P. A., Kasiske, B. L., Kelepouris, E., Klag, M. J., Parfrey, P., Pfeffer, M., Raij, L., Spinosa, D. J., Wilson, P. W. (2003). Kidney Disease as a Risk Factor for Development of Cardiovascular Disease: A Statement From the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention. Circulation 108: 2154-2169 [Full Text]  
• Sharma, A.M. (2003). Renal involvement in hypertensive cardiovascular disease. Eur Heart J Suppl 5: F12-F18 [Abstract]  
• Levey, A. S., Coresh, J., Balk, E., Kausz, A. T., Levin, A., Steffes, M. W., Hogg, R. J., Perrone, R. D., Lau, J., Eknoyan, G. (2003). National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification. ANN INTERN MED 139: 137-147 [Abstract] [Full Text]  
• Pitts, D. B., Goto, A., Levey, A. S. (2003). Nondiabetic Kidney Disease. NEJM 348: 762-763 [Full Text]